Rongfeng Fu

14PUBLICATIONS
42CO-AUTHORS
Adolescent healthEconomic models and forecastingAutoimmunityTissue engineeringInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 16, 2026
Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial.

|Aug 18, 2026
External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.

|Apr 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.

|Mar 12, 2026
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity.

Wei Liu, Xiaolei Pei, Tenghui Yu

|Oct 07, 2024
Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort.

Rongfeng Fu, Huan Dong, Wenjing Gu

|Sep 27, 2024
Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential Thrombocythemia.

Huan Dong, Jia Chen, Jing Zhang

Pageof 3

Frequent Collaborators

14 joint publications

Lei Zhang

10 joint publications

Yunfei Chen

8 joint publications

Feng Xue

6 joint publications

Wei Liu